Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy. 1967

I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010633 Phenmetrazine A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. Defenmetrazin,Fenmetrazin,Oxazimedrine,Phenmetraline,Phenmetrazine Hydrochloride,Preludin,Hydrochloride, Phenmetrazine
D002745 Chlorphentermine A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223) Avipron,Chlorphentermine Hydrochloride,Desopimon,Pre-Sate,Hydrochloride, Chlorphentermine
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
December 1969, Current therapeutic research, clinical and experimental,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
September 1967, Current therapeutic research, clinical and experimental,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
January 1973, Psychotherapy and psychosomatics,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
November 1967, Current therapeutic research, clinical and experimental,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
February 1968, Clinica chimica acta; international journal of clinical chemistry,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
February 1964, The Medical journal of Australia,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
April 1971, Deutsche medizinische Wochenschrift (1946),
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
January 1991, Family medicine,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
January 2022, Acta scientiarum polonorum. Technologia alimentaria,
I W Sletten, and V Ognjanov, and S Menendez, and D Sundland, and A el-Toumi
January 2002, Sbornik lekarsky,
Copied contents to your clipboard!